SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anupam Rasayan surges on bagging order of Rs 1100 crore from Multinational Life Sciences Company

28 Apr 2021 Evaluate

Anupam Rasayan is currently trading at Rs. 651.80, up by 23.15 points or 3.68% from its previous closing of Rs. 628.65 on the BSE.

The scrip opened at Rs. 642.00 and has touched a high and low of Rs. 666.00 and Rs. 636.70 respectively. So far 29681 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 666.00 on 28-Apr-2021 and a 52 week low of Rs. 472.25 on 31-Mar-2021.

Last one week high and low of the scrip stood at Rs. 666.00 and Rs. 549.00 respectively. The current market cap of the company is Rs. 6440.50 crore.

The promoters holding in the company stood at 65.40%, while Institutions and Non-Institutions held 7.50% and 27.11% respectively.

Anupam Rasayan has received and signed Letter of Intent (LOI) amounting to Rs 1100 crore from one of the top ten Multinational Life Sciences Company, for supplying life sciences related specialty chemicals. The company will provide multiple products in the category to the multinational firm for next five years.  The specialty chemicals major is manufacturing products for over 53 domestic and international customers, including 17 multinational companies.

Anupam Rasayan India is one of the leading companies engaged in the custom synthesis and manufacturing of specialty chemicals in India.

Anupam Rasayan India Share Price

1289.10 21.10 (1.66%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3703.10
Tata Chemicals 709.05
SRF 2493.65
Pidilite Inds. 1393.25
Deepak Nitrite 1538.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×